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depression-like behaviors in female but not male
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Human and animals studies support the idea that there is a gender-related co-morbidity of pain-related and
inflammatory gastrointestinal (GI) diseases with psychological disorders. This co-morbidity is the evidence for the
existence of GI-brain axis which consists of immune (cytokines), neural (vagus nerve) and neuroendocrine (HPA axis)
pathways. Psychological stress causes disturbances in GI physiology, such as altered GI barrier function, changes in
motility and secretion, development of visceral hypersensitivity, and dysfunction of inflammatory responses.
Whether GI inflammation would exert impact on psychological behavior is not well established. We examined the
effect of experimental gastritis on anxiety- and depression-like behaviors in male and female Sprague–Dawley rats,
and evaluated potential mechanisms of action. Gastritis was induced by adding 0.1% (w/v) iodoacetamide (IAA) to
the sterile drinking water for 7 days. Sucrose preference test assessed the depression-like behavior, open field test
and elevated plus maze evaluated the anxiety-like behavior. IAA treatment induced gastric inflammation in rats of
either gender. No behavioral abnormality or dysfunction of GI-brain axis was observed in male rats with
IAA-induced gastritis. Anxiety- and depression-like behaviors were apparent and the HPA axis was hyperactive in
female rats with IAA-induced gastritis. Our results show that gastric inflammation leads to anxiety- and
depression-like behaviors in female but not male rats via the neuroendocrine (HPA axis) pathway, suggesting that
the GI inflammation can impair normal brain function and induce changes in psychological behavior in a
gender-related manner through the GI-to-brain signaling.
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The high co-morbidity between gastrointestinal (GI) dis-
eases, including irritable bowel syndrome (IBS), inflamma-
tory bowel disease (IBD) and functional dyspepsia (FD),
and psychological symptoms such as depression and anx-
iety is the evidence for existence of GI-brain axis [1-8].
Many researches on this field have focused on the patho-
genic role of psychological stress based on the primary ob-
servation that psychological stress induces modifications of
motility, secretion, visceral sensitivity, and local inflamma-
tory responses in the GI tract [9,10]. However, in recent
years a growing body of studies provides compelling evi-
dences to suggest that not only can the brain affect GI* Correspondence: jinfeng@psych.ac.cn
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reproduction in any medium, provided the oractivity, but that the GI activity can also induce changes in
brain function [11-13]. There are three potential pathways
that have been proposed so far, through which GI signals
can be transmitted to and induce changes in brain function:
immune (cytokines), neural (vagus nerve) and neuroendo-
crine (corticosterone/HPA axis) pathways [1,14].
In this study, to examine whether GI inflammation af-
fected psychological behavior, the anxiety- and depression-
like behaviors were assessed following induction of gastritis
in Sprague–Dawley rats. Gastritis was induced by adding
0.1% (w/v) iodoacetamide (IAA) to the sterile drinking
water for 7 days. The activities of the three GI-brain axis
pathways through which gastric inflammation may modu-
late the brain function and behavior were also evaluated.
Since these pain-related and inflammatory GI diseases have
a considerably higher prevalence in women than in men
[15-19], we tested both male and female rats in order to. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tritis on psychological behavior. Data provided by ample
studies in gonadectomy animals propose sex hormone as
an obvious candidate to explain the sexual dimorphism in
behaviors [20,21]. Therefore, we also measured the plasma
levels of 17ß-estradiol and testosterone in female and male
rats respectively.
Materials and methods A
Animals
Specific-pathogen-free male and female Sprague–Dawley
rats, 8–9 week old, (VITAL RIVER Animal Centre, Beijing,
China) were used in the study. All rats were housed indi-
vidually in wire-mesh cages in animal rooms with
controlled temperature at 20 ± 2°C, a relative humidity of
50% − 55%, and a 12:12 h light/ dark cycle. They had free
access to standard laboratory rodent chow and fresh sterile
drinking water. Four groups of animals were included in
the study: control group (C group) and iodoacetamide-
treated group (IAA group) of male and female rats. Female
rats were housed in another room away from male rats.
Experiment protocols
After two-week acclimatization (day 1–14), IAA groups
were treated with iodoacetamide via drinking water for
7 days (day 15–21). The control groups drank the fresh
sterile water throughout the whole experiment. The
drinking volumes (ml/g body weight) recorded at experi-
ment days 8 and 15 were used for calculation of the
drinking volumes during days 1–14 and 15–21 respect-
ively. Since there is evidence that behavioral test may it-
self has a gender-related effect on biochemical activity
[22], the biochemical markers and psychological behav-
iors were parallelly assessed in two parts of rats follow-
ing 7-day IAA treatment. One day after the 7-day IAA
treatment period (day 22), each group with 6 rats was
sacrificed by decapitation. The trunk blood and gastric
tissue were collected, and the brain was removed imme-
diately for further dissection. Simultaneously, a sequence
of behavior tests started from day 22 was carried out in
each group with 6–8 rats, during which the animals con-
tinued to drink either sterile water or water containing
IAA. The experimental protocol was approved by the
Animal Experiment Ethics Committee of the Institute of
Psychology, Chinese Academic of Sciences.
Induction of gastritis
Iodoacetamide (IAA) was purchased from Sigma Chemical
Company, St. Louis, MO, USA. Gastritis was induced by
addition of 0.1% (w/v) IAA to drinking water for 7 succes-
sive days, based on the model described by Karmeli et al.
who showed a maximum increase in gastric inflammation
and lesion for this period of administration [23]. Since IAA
is light sensitive, the light-limiting drink bottles were used,and the IAA-containing drinking water was refreshed every
day.Behavioral tests
Behavioral tests were conducted in sequential order of
sucrose preference test (SPT), open field test (OFT), ele-
vated plus maze (EPM). The SPT examined depression-
like behavior, while OFT and EPM were used to evaluate
anxiety-like behavior.Sucrose preference test (SPT)
This consisted of a 48 hours training session and a
1 hour test session conducted 24 hours after the training
session [13,24]. In the training session, singly housed
rats were trained for 48 hours to drink sugar water in a
cage containing two bottles, one bottle containing 1%
sucrose solution and another one containing sterile
water. The bottles were switched every 12 hours to pre-
vent possible effects of side preference in drinking be-
havior. Afterwards, only sterile water was provided for
6 hours. Then food and water were withheld from rats
for 18 hours. In the test session, rats got access to two
bottles with 1% sucrose solution and water, respectively,
for one hour. Sucrose preference was evaluated accord-
ing to the formula below: Sucrose preference (SP) = [su-
crose intake (ml)/(sucrose intake (ml) + water intake
(ml))] × 100.Open field test (OFT)
The open field apparatus consisted of an arena (100 cm ×
100 cm× 40 cm) made of black polypropylene [25]. Rats
were individually placed into the corner of the field, and
allowed to explore the arena for 5 minutes. Movements
were recorded by a video camera mounted above the center
of the arena, and analyzed using the ANY-Maze video
tracking system (Stoelting CO, USA).Elevated plus maze (EPM) test
The EPM apparatus consisted of a center area (10 × 10 cm)
with two opposite closed (10 cm wide, 50 cm long, 30 cm
high wall at their sides and the far end) and two opposite
open arms (10 cm wide, 50 cm long) arranged in the shape
of a plus. The device was made of opaque black polypropyl-
ene and elevated 50 cm above the floor [26].
Rats were placed individually on the center of the
maze facing an open arm and were allowed 5 minutes of
free exploration. The movements of the animals during
the 5-minute test period were tracked by a video camera
positioned above the center of the maze and were ana-
lyzed using ANY-Maze (Stoelting CO, USA) video track-
ing system.
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gastric tissue
Full-thickness sample of the gastric corpus (100–120 mg)
was excised and the gastric MPO activity was determined
according to the previously described spectrophotometric
technique [27,28]. MPO is granule-associated enzyme pri-
marily contained in neutrophils, correlates well with the se-
verity of the inflammation and histological lesion, and its
measurement has been widely used as a marker of gastro-
intestinal inflammation. MPO activity was expressed as
units per milligram of wet tissue, where one unit of MPO
was defined as the quantity of the enzyme able to convert
1 μ mol hydrogen peroxide to water in 1 minute at room
temperature.
Enzyme-linked immunosorbent assay (ELISA) analysis
The trunk blood was collected and centrifuged (1500 × g,
10 min, 4°C). Plasma was taken and immediately stored at
−80°C until assayed. Cytokines including interleukin-6
(IL-6), interferon-gama (INF-γ), and tumor necrosis factor-
alpha (TNF-α) (IBL, Minneapolis, USA), as well as sex hor-
mones including 17ß-estradiol and testosterone, and
corticosterone (Abcam, Cambridge, UK) in plasma were
measured using ELISA kits, according to the manufac-
turer’s instructions.
RNA isolation and reverse transcription
RNA was isolated from hypothalamus (50–70 mg) using
TRNzol reagent according to the manufacturer’s instruc-
tions (Tiangen Biotech Co. Ltd., Beijing, China). 4 μl of
total RNA from each sample was converted to double-
stranded cDNA using TIANScript Reverse Transcription
Kit (Tiangen Biotech Co. Ltd., Beijing, China). Subse-
quently, 2 μl of the resulting cDNA samples were used
in the following quantitative real-time PCR (qPCR) for
measurement of mRNA expressions of Gapdh (housing
keep gene), C-fos, corticotropin-releasing factor (Crf )
and glucocorticoid receptor (Gr).
Quantitative real-time polymerase chain reaction (qPCR)
The qPCR reaction was performed in a Real Time PRC
system (Applied Biosystems, model 7300) using SYBR®
Premix Ex Taq™ (Takara Bio, Japan). The primers used in
this study were listed in Table 1. Primers were validated
previously to exclude cross reactivity [29-32].Table 1 Primer sequences used for real-time PCR




GR AGGGGAGGGGGAGCGTAATGG CCTCTGCTGCTTGGAATCTGCRelative quantification was analyzed with the 7300 system
SDS software, and the mean 2-△CT was calculated for each
sample. Results were presented as percentage expression
relative to Gapdh.Statistical analysis
Results were presented as means ± standard error of mean
(S.E.M). In all statistical comparisons, two-tailed, p < 0.05,
were regarded as significant difference. Statistical evaluation
of the results was performed on SPSS 17.0 (SPSS Inc.,
Chicago, IL, USA) with two-way analysis of variance
(ANOVA) to identify gender differences, treatment effects
and the interaction between these factors. The homogeneity
of variance was analyzed with the Levene test. When the
significance was reached with the ANOVA, a post-hoc test
(Tukey HSD test) was employed.Results
Gastric myeloperoxidase (MPO) activity
As shown in Figure 1, MPO activity was significantly in-
creased (ANOVA for factor treatment: F(1, 20) = 78.59,
p < 0.001) in IAA-treated rats as compared with control
rats. The IAA-induced increase in MPO activity was similar
between male and female rats (ANOVA for factor gender:
F(1, 20) = 0.265, p > 0.05), whereas female control rats had a
greater (p < 0.05) MPO activity than male control rats. The
interaction between the factors treatment and gender was
significant (F(1, 20) = 4.81, p < 0.05).Figure 1 The IAA treatment induces an increase in gastric MPO
activity in rats of either gender. IAA, iodoacetamide. Values are
means ± S.E.M of six rats. *p < 0.05 was significantly different from
control group of the same gender. +p < 0.05 was significantly
different from male control group.
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Sucrose preference test (SPT)
In the SPT, the sucrose preference was taken as indices of
depression. As shown in Figure 2, the IAA treatment sig-
nificantly reduced the sucrose preference (ANOVA for fac-
tor treatment: F(1, 24) = 12.79, p < 0.01). Moreover, the
interaction between the factors treatment and gender was
significant (F(1, 24) = 13.80, p = 0.001). The sucrose prefer-
ence was significantly (p < 0.05) decreased only in female
but not (p > 0.05) male IAA-treated rats, while in control
rats the sucrose preference did not exhibit any gender dif-
ference (p > 0.05).Behavior test for anxiety-like behavior
Open field test (OFT)
In the OFT, the number of entries into, the time spent
and the distance traveled in the center zone were taken
as indices of anxiety. These parameters were expressed
as a percentage of the total entries into, the total time
spent and the total distance traveled in the center zone
during the 5 min test session.
The Figure 3A demonstrated that the IAA treatment had
no effect on the number of entries into the central zone
(ANOVA for factor treatment: F(1, 24) = 3.49, p > 0.05). The
number of entries into the central zone was similar be-
tween IAA-treated and control rats of the same gender.
The IAA treatment significantly reduced the time spent
and distance traveled in the central zone (ANOVA for fac-
tor treatment: F(1, 24) = 14.91, p = 0.001; F(1, 24) = 7.98,Figure 2 The female but not male rats with IAA-induced gastritis
develop depression-like behavior. The sucrose preference test
was used to measure depression. The sucrose preference correlated
negatively with the depression state. IAA, iodoacetamide. Values are
means ± S.E.M. *p < 0.05 was significantly different from control group
of the same gender. N = 8 rats/male group, N = 6 rats/female group.p < 0.01). The interaction between the factors treatment
and gender was significant (central zone time: F(1, 24) =
6.67, p < 0.05; central zone distance: F(1, 24) = 4.62,
p < 0.05). However, the central zone time and distance were
decreased (p < 0.01; p < 0.01) only in female but not male
IAA-treated rats, while female control rats spent signifi-
cantly (p < 0.001; p < 0.01) more time and distance in the
central zone than male control rats.
Elevated plus maze (EPM)
In the EPM, the number of entries into, the time spent
and the distance traveled in the open arms were taken as
indices of anxiety. These parameters were expressed as a
percentage of the total entries into, the total time spent
and the total distance traveled in any arm during the
5 min test session.
In Figure 3B, the IAA treatment had no effect on the
number of entries into the open arms (ANOVA for factor
treatment: F(1, 24) = 4.18, p > 0.05). The number of entries
into the open arms was similar between IAA-treated and
control rats of the same gender. The IAA treatment signifi-
cantly reduced the time spent and distance traveled in the
open arms (ANOVA for factor treatment: F(1, 24) = 6.88,
p < 0.05; F(1, 24) = 8.67, p < 0.01). The interaction between
the factors treatment and gender was significant (open arm
time: F(1, 24) = 16.23, p < 0.001; open arm distance: F(1, 24) =
23.73, p < 0.001). However, the open arm time and distance
were decreased (p < 0.01; p < 0.001) only in female but not
in male IAA-treated rats, while in control rats the time
spent and distance traveled in open arms did not exhibit
any gender difference (p > 0.05; p > 0.05).
Plasma levels of pro-inflammatory cytokines
Male and female control rats did not differ in plasma con-
centrations of IL-6 (47.91 ± 2.62 pg/ml vs 40.80 ± 2.71 pg/
ml, p > 0.05), TNF-α (134.10 ± 11.84 pg/ml vs 123.88 ±
8.26 pg/ml, p > 0.05) and INF-γ (898.68 ± 77.66 pg/ml vs
805.09 ± 51.85 pg/ml, p > 0.05). Furthermore, the IAA
treatment had no effect on plasma levels of IL-6, TNF-α
and INF-γ (ANOVA for factor treatment: F(1, 20) = 0.27,
p > 0.05; F(1, 20) = 0.29, p > 0.05; F(1, 20) = 1.66,
p > 0.05). The concentrations of IL-6, TNF-α and INF-γ
did not differ between IAA-treated and control rats of the
same gender. Plasma levels of IL-6, TNF-α and INF-γ in
male IAA-treated rats were 49.64 ± 3.91 pg/ml, 118.18 ±
8.18 pg/ml and 830.98 ± 44.98 pg/ml, in female IAA-
treated rats were 42.41 ± 3.50 pg/ml, 149.95 ± 9.00 pg/ml
and 923.51 ± 40.11 pg/ml.
C-fos mRNA expression in hypothalamus
The hypothalamic C-fos expressions were similar be-
tween male and female control rats (0.54 ± 0.09% vs
0.49 ± 0.13%, p > 0.05). The IAA treatment had no effect
on hypothalamic C-fos expression (ANOVA for factor
Figure 3 The female but not male rats with IAA-induced gastritis develop anxiety-like behavior. (A) Female rats with IAA-induced gastritis
spend less time and travel less distance in the central zone of open field test (OFT). (B) Female rats with IAA-induced gastritis spend less time
and travel less distance in the open arms of elevated plus maze (EPM). The OFT and EPM evaluated the anxiety-like behavior. The percentages of
the number of entries into, the time spent and the distance traveled in the center zone of OFT and in the open arm of EPM correlated negatively
with the anxiety state. IAA, iodoacetamide. Values are means ± S.E.M. *p < 0.05 was significantly different from control group of the same gender.
+p < 0.05 was significantly different from male control group. N = 8 rats/male group, N = 6 rats/female group.
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between the factors treatment and gender was not
significant.
The activity of hypothalamic–pituitary–adrenal (HPA) axis
Corticotropin-releasing factor (Crf) mRNA expression in
hypothalamus
As shown in Figure 4A, the IAA treatment significantly in-
creased the hypothalamic Crf expression (ANOVA for fac-
tor treatment: F(1, 20) = 14.56, p = 0.001). The interaction
between the factors treatment and gender was significant
(F(1, 20) = 13.52, p = 0.001). The hypothalamic Crf expres-
sion was only increased (p = 0.001) in female but not in
male IAA-treated rats, while male and female control rats
did not differ in hypothalamic Crf mRNA expression
(1.35 ± 0.23% vs 0.97 ± 0.15%, p > 0.05).
Glucocorticoid receptor (Gr) mRNA expression in
hypothalamus
The Figure 4B revealed that the hypothalamic Gr mRNA
expressions were significantly greater in female than in
male control rats (1.08 ± 0.11% vs 0.60 ± 0.05%, p < 0.01).
The interaction between the factors treatment and gender
was significant (F(1, 20) = 11.85, p < 0.01). Furthermore, it
was found that IAA treatment induced a drop (p < 0.001)
in Gr expression only in female rats, but not in male rats.
Plasma levels of corticosterone (CORT)
In Figure 4C, IAA treatment significantly reduced (ANOVA
for factor treatment: F(1, 20) = 17.91, p < 0.001) plasma
CORT levels. The interaction between the factors treatmentand gender was significant (F(1, 20) = 16.52, p = 0.001). The
CORT levels were decreased (p = 0.001) only in female but
not (p > 0.05) male IAA-treated rats, whereas female con-
trol rats had a higher CORT levels than male control rats
(285.12 ± 5.32 ng/ml vs 264.38 ± 6.38 ng/ml, p < 0.05).Plasma levels of sex hormones: 17ß-estradiol and
testosterone
IAA treatment induced a reduction (p < 0.01) in plasma
17ß-estradiol levels in female rats (Figure 5A). Figure 5B
showed that male rats treated with IAA had a higher testos-
terone level than male controls (194.35 ± 6.37 pg/ml vs
141.99 ± 6.56 pg/ml, p < 0.001).Daily drank water
Rats significantly drank less (ANOVA for factor treat-
ment: F(1, 20) = 131.69, p < 0.001) IAA water than the
normal drinking water. The IAA-induced reduction in
drank water was similar between male and female rats
(ANOVA for factor gender: F(1, 20) = 0.928, p > 0.05),
while during acclimatization period (day 1–14), the daily
drank water was not significantly different (0.160 ±
0.011 ml/g vs 0.139 ± 0.011 ml/g, p > 0.05) between male
and female control rats. As a result, during day 15–21,
male and female rats drank similar volume of water-
containing IAA (0.0528 ± 0.003 ml/g vs 0.0578 ±
0.003 ml/g, p > 0.05). The interaction between the fac-
tors treatment and gender was not significant (F(1, 20) =
2.429, p > 0.05).
Figure 4 The IAA treatment induces hyperactivity of HPA axis in female but not male rats. (A) Crf mRNA expression in hypothalamus is
increased in female rats with IAA-induced gastritis. (B) Gr mRNA expression in hypothalamus is reduced in female rats with IAA-induced gastritis.
(C) Plasma levels of CORT are decreased in female rats with IAA-induced gastritis. The hypothalamic expressions of corticotropin-releasing factor
(CRF) and glucocorticoid receptor (GR), and plasma levels of corticosterone (CORT) were used to assess the HPA axis activity. IAA, iodoacetamide.
Values are means ± S.E.M of six rats. *p < 0.05 was significantly different from control group of the same gender. +p < 0.05 was significantly
different from male control group.
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Effect of gastric inflammation on psychological behaviors
in male and female rats
In view of the growing evidence that pain-related and in-
flammatory GI diseases are linked to anxiety and depres-
sion symptoms, the overall aim of our study was to test
a possible relationship between gastric inflammation and
psychological behaviors in rats. While it has previously
been shown that psychological stressors such as
experimentally induced depression- and anxiety-like
phenotypes enhance the vulnerability to intestinal in-
flammation [33-35], we here explore whether GIinflammation has an impact on anxiety- and depression-
like behaviors in rats.
The IAA added to drinking water at a concentration
of 0.1% for 7 days has been previously shown to elicit
murine gastric inflammation. In the present study we
observed that the gastric inflammation was successfully
induced by IAA treatment in rats of either gender, as
assessed by increased MPO activities in IAA-treated rats.
A potential drawback of IAA-induced gastritis model is
the significant reduction of water intake [36,37]. None-
theless, previous reported analysis of the circadian activ-
ity patterns revealed that IAA reduced drinking, feeding
Figure 5 The IAA treatment causes changes in sex hormones in rats of either gender. (A) Plasma levels of 17ß-estradiol are decreased in
female rats with IAA-induced gastritis. (B) Plasma levels of testosterone are increased in male rats with IAA-induced gastritis. IAA, iodoacetamide.
Values are means ± S.E.M of six rats. *p < 0.05 was significantly different from control group of the same gender.
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significant extent, suggesting that the reduction of water
intake is not primarily taste-related but, together with
the decrease in feeding and locomotor activity, reflects a
behavioral consequence of gastritis [22]. The normal ap-
petite for sucrose and water should be reserved in gastri-
tis rats. Moreover, the sucrose preference test has been
used extensively to measure anhedonia, a core symptom
of depression, in mild stress models of depression
[38-40]. Strekalova et al. [24] found that anhedonia was
associated with analogues of depressive symptoms, such
as increased floating during forced swimming and de-
creased exploration of novelty. Thus, the sucrose prefer-
ence of IAA-treated rats reflects their depression scores.
The significant interaction between the factors treat-
ment and gender on anxiety- and depression-like behav-
iors may indicate that the IAA-induced gastritis has a
gender-related effect on psychological behaviors. The fe-
male rats with IAA-induced gastritis exhibited anxiety-
and depression-like behaviors as assessed in SPT, OPT
and EPM tests. Nevertheless, IAA treatment failed to
affect the psychological behaviors in male rats. Although
it could be argued that IAA treatment failed to reduce
the time and distance that male rats spent and traveled
in the central zone of the open field, because male con-
trol rats spent significantly less time and traveled less
distance in the central zone than female control rats,
this argument is not applicable to the time spent and the
distance traveled in the open arms of EPM in which
male and female control rats did not significantly differ.
The gender-related behavioral response to experimental
gastritis is not an unexpected finding. Firstly, there is clin-
ical evidence for a gender-related co-morbidity of func-
tional dyspepsia with anxiety and depression as we have
discussed before [6,8,19]. Secondly, the IAA-inducedgastritis in rats has previously been shown to elicit hyper-
sensitivity to both mechanical and chemical noxious stimu-
lation of the stomach, and has been proposed to represent
an experimental model of functional dyspepsia [13,37,41].
The gastric inflammation could influence the psycho-
logical behavior via the three potential pathways of
GI-brain axis including immune, vagal nerve and neuro-
endocrine pathways. The gender-related increase in anx-
iety and depression due to gastritis went in parallel with
the changes in the three GI-to-brain pathways. The IAA
treatment had no effect on pro-inflammatory cytokines
levels in plasma. In male rats, a normal behavior is in
line with the lack of effect of IAA treatment on pro-
inflammatory cytokines. However, the lack of effect of
IAA treatment on plasma levels of pro-inflammatory cy-
tokines (IL-6, TNF-α and INF-γ) in female rats may
suggest that the gender-related impact of gastric inflam-
mation on psychological behaviors is not mediated by
the circulating immune pathway. The vagus nerve is an-
other route for the GI-to-brain signaling. When the
vagus nerve is activated, information carried by vagal af-
ferent from gastrointestinal tract is transmitted to the
nucleus tractus solitaries (NTS), the site of primary af-
ferent termination of the vagus nerve — before areas in-
volved in the stress response such as the paraventricular
nucleus of the hypothalamus [42-44]. It has been shown
that stimuli induces expression of c-fos expression in
neurons in the NTS, and also in the PVN of hypothal-
amus [45,46]. Moreover, data provided by studies in va-
gotomy animals showed that the stress-induced c-fos
expression in PVN was reduced by vagotomy [47-49],
suggesting the neuronal activity in PVN can reflect the
vagus nerves activity.
Expression of c-fos, either C-fos mRNA or c-Fos pro-
tein levels (c-Fos protein-positive neurons), is an indirect
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expressed when neurons fire action potentials. Emerging
body of literature presents ample evidences that C-fos
mRNA expression can be used as a tool to assess neur-
onal activation [50-55]. Moreover, data from previous
studies have shown that the C-fos mRNA expression was
significantly correlated with c-Fos protein expression in
neurons of brain regions [56-59]. Therefore, we evalu-
ated the vagus nerve activity by measuring the mRNA
expression of C-fos in the hypothalamus. There is a non-
significant interaction between the treatment and gender
on hypothalamic C-fos expressions. No significant differ-
ence in hypothalamic C-fos mRNA expressions between
female rats with IAA-induced gastritis and female con-
trols may indicate that the vagal nerves do not mediate
the gender-related impact of gastric inflammation on
psychological behavior in the present study. Neverthe-
less, it is important to emphasize that the entire hypo-
thalamus may be a relatively extensive size of brain
region compared to PVN, and may not be effective in
the assessment of vagus afferent activity. Therefore,
these results must be interpreted with caution. The ob-
served lack of effect of IAA treatment on hypothalamic
c-fos expression seems to be in contrast to the many re-
ports that describe an induction of c-fos expression in a
variety of brain areas in response to a wide range of
stressors, including restraint, swimming, audiogenic
noise and immune challenge [60-63]. However, these
stressors that induce c-fos expression are acute stressors.
Data from ample studies have suggested that habituation
to chronic stress could induce the lack of stress-induced
c-fos expression in the PVN of hypothalamus [64-67].
Tan et al. [64] have shown that expression of c-fos in
the hypothalamic PVN region of the brain was induced
and reached a peak at 0.5 hours for C-fos mRNA and
4 hours for c-Fos protein, but disappeared at 2 hours for
C-fos mRNA and 16 hours for c-Fos protein during con-
tinuous restraint stress. Moreover, despite the lack of ef-
fect of chronic stress on c-fos expression in the PVN,
the CRF expression in PVN and plasma CORT levels
were found to be markedly changed during chronic
stress [64,68,69]. This dissociation between c-fos and
CRF expression in PVN during chronic stress is in line
with the results of the current study that the 7-day-IAA
induced gastritis causes gender-related alterations in
hypothalamic mRNA expressions of Crf and Gr and
CORT levels in plasma, but had no effect on hypothal-
amic C-fos mRNA expression.
Either neural excitatory input to the PVN (represented
primarily by c-fos expression) or the ability of cells in
the PVN to respond to that input (represented primarily
by CRF expression) could activate the HPA axis negative
feedback [70]. Double-labelling studies have shown that
the majority of cells in the PVN that express c-Fos inresponse to stressful stimuli can also express CRF [71].
The dissociation between hypothalamic C-fos and Crf
mRNA expressions observed in our study may indicate
that dysregulation of HPA axis induced by gastritis
stress is not a result of increased excitatory neural in-
put to the PVN, but instead depends on some direct
effect of gastritis on cells intrinsic to the HPA axis.
Similar results were reported in the Sprague–Dawley
rat following restraint stress with glucocorticoid pre-
treatment [70].
The hypothalamic-pituitary-adrenal (HPA) axis plays a
prominent role in the neuroendocrine route for the GI-
to-brain signaling. The HPA axis activation is a homeo-
static mechanism that is triggered by a physical or
psychological stress to release corticotropin-releasing
factor (CRF) and terminated by the negative feedback
action that elevations in circulating CORT inhibit the
HPA axis by acting via the glucocorticoid receptor (GR)
[72]. The significant interaction between the factors
treatment and gender on plasma levels of corticosterone
and hypothalamic mRNA expressions of Gr and Crf may
suggest that the IAA-induced gastritis has a gender-
related effect on the HPA axis activity. The HPA axis
activity was altered in female but not male rats with
IAA-induced gastritis, as reflected by decreases in hypo-
thalamic Gr mRNA expression and blood CORT levels,
and an increase in hypothalamic Crf mRNA expression.
These alterations are likely to indicate a hyperactivity of
HPA axis due to reduced sensitivity to the negative feed-
back action of CORT. HPA axis hyperactivity is a con-
sistent finding among patients with major depression
disorder [73], and anxiety disorders including panic dis-
order [74], social anxiety disorder [75] and generalized
anxiety disorder [76]. Although it could be argued that
IAA treatment failed to reduce the hypothalamic Gr
mRNA expression and plasma CORT levels in male rats,
because the hypothalamic Gr mRNA expression and
plasma CORT levels were significantly less in male than
in female control rats, this argument is not applicable to
the hypothalamic Crf mRNA expression in which male
and female control rats did not significantly differ.
Hyperactivity of HPA axis is primarily characterized by
an elevation in central CRF expression which also has
been demonstrated to play a prominent role in the eti-
ology of anxiety and depression. Intracerebroventricular
administration of CRF reduces the open arm exploration
in the EPM and also has anxiogenic effect in other anx-
iety tests [77]. In clinical studies, individuals with de-
pression, anxiety or suicide exhibit more CRF neu-
rons in hypothalamus than normal individuals [78].
Altogether, the gastric inflammation, the hyperactivity of
HPA axis, in combination with the anxiety- and
depression-like behaviors in female IAA-treated rats sug-
gest that gastric inflammation has a gender-related
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Rats developed gastric inflammation following 7-day
IAA treatment, since the IAA treatment increased the
gastric MPO levels in rats of either gender. Furthermore,
a significant interaction between the factors treatment
and gender in MPO activity may suggest there is a gen-
der difference in sensitivity of IAA-induced gastritis. Al-
though female control rats have a higher MPO levels
than male control rats, the IAA treatment still signifi-
cantly increases the MPO activity in both genders. It
may suggest that female rats are more vulnerable to
IAA-induced gastritis than male rats. This gender differ-
ence in sensitivity of IAA-induced gastritis is consistent
with the clinical findings that GI disorder has a consid-
erably higher prevalence in women than in man [15-17].
Therefore, we consider that the gender-related effect of
gastritis on anxiety and depression as well as HPA axis
activity may be related to the sensitivity to gastritis
which was greater in female than in male rats.
Association between sex hormones and the gender-related
anxiety- and depression-like behaviors
Data from animal and clinical studies may also provide
some evidences for clarifying the mechanism by which
gastric inflammation affects the HPA axis activity and
psychological behaviors in a gender-related manner.
There is an ample body of literatures that propose the
sex hormone as an obvious candidate to explain the be-
havioral and physiological gender differences [20,21,79].
The sex hormones in female and male rats respectively
are 17ß-estradiol and testosterone which are demonstrated
to modulate the HPA axis response to stressors. In the ro-
dent, the HPA axis responses to endotoxin and to IL-1 are
enhanced by gonadectomy and attenuated by estradiol and
testosterone replacement [80]. Data from clinical study
have also shown that following a precipitous decline in es-
tradiol levels during pregnancy, postpartum women experi-
ence greater HPA axis response to stressors [81]. Therefore,
in our study, a decline in estradiol level in female IAA-
treated rats may lead to an enhanced HPA axis response to
gastric inflammation, while an increase in testosterone level
in male IAA-treated rats may reserve a normal HPA axis
response to gastric inflammation.
Furthermore, since the HPA axis activity has been shown
to regulate psychological behaviors, the alterations in sex
hormones may be relevant to the gender-related anxiety-
and depression-like behaviors in rats with IAA-induced
gastritis. Data from previous studies have provided evi-
dences for an association between decreased sex hormones
and increased susceptibility to anxiety and depression. Post-
partum depression, as well as premenstrual syndrome, pre-
menstrual dysphoric disorder and menopause depression
are all associated with a drop in circulating estrogen [81].In addition, men with hypogonadism, a condition where
the body produces no or low testosterone, suffer increased
levels of depression and anxiety, while testosterone replace-
ment therapy has been shown to effectively improve mood
[82,83].
It is well known that cyclical female sex hormone vari-
ation has a profound effect on behavioral and neuro-
chemical parameters. Although this can be important,
the short duration of the estrous cycle in rats coupled
with the duration of the study and the fact that female
rats housed in the same room can phase into the same
estrous cycle stage [84] would most likely result in not
having a differential predominance of animals in any one
particular phase of the cycle across groups [85], and ex-
clude the possibility of confounding behavioral effects of
different phases of the cycle during the same testing ses-
sions [86-89].
Conclusions
In summary, our results show that the IAA-induced gas-
tric inflammation leads to anxiety- and depression-like
behaviors in female but not male rats via the neuro-
endocrine pathway, suggesting GI inflammation has a
gender-related impact on psychological behavior and
providing evidence for the existence of GI-to-brain sig-
naling. This gender-related behavioral effect of gastric
inflammation may be related to the different sensitivity
to gastritis and the changes in sex hormones. Further
studies are required to define how these changes, that
happen locally in GI, at the molecular level contribute
to the regulation of brain function and behavior in a
gender-related manner.
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